The­seus goes with Tang; Onc­ter­nal tri­al pa­tient dies; Lian­Bio sells drug rights to J&J

Plus, news on the Im­munome-Atre­ca as­set deal, Cy­clo Ther­a­peu­tics’ re­verse merg­er, Nestlé buy­ing CDX-7108 from Codex­is, Onc­ter­nal, Vi­siox and more.

So long, Ap­plied Mol­e­c­u­lar …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER